Navigation Links
Report: Global Market for Dialysis Care Nears 90 Billion Dollars
Date:4/13/2015

NEW YORK, April 13, 2015 /PRNewswire/ -- The market for dialysis products and services reached $89.8 billion in 2014, according to Kalorama Information. The healthcare market research firm said that the expansion of the dialysis industry has resulted in improvements in the overall mortality rates of the dialysis patients with the marked reduction in adjusted 1-year death rates for dialysis patients across the world. However, the overall cost of dialysis care has increased substantially (both outpatient and inpatient care costs), while reimbursement rates have remained the same or have been adjusted slightly. The finding was made in Kalorama Information's fourth report on the dialysis market since 2009, World Market for Dialysis Equipment and Services.

The healthcare market research firm says that a large number of competitors share in that market - the dialysis products and services market is a highly fragmented. Global players account for only a fraction of the total market and rest is occupied by the regional companies and government providers. Fresenius is the leader in this market and Kalorama believes will continue to dominate the scene owing to its vast product line and vertical integration into lucrative and big dialysis care segment.  

"Companies with dialysis centers have made a substantial leap in terms of revenues, but they've been able to benefit from that ownership" said Bruce Carlson, Publisher of Kalorama Information. "Owning centers/clinics has helped these companies in increasing their clout in product markets."

Products include dialysis machines as well as the related tubing and fistulas. Kalorama breaks out product and services markets in its report and makes projections for both. 

Conditions such as increasing diabetes are a driver of both markets. According to Kalorama's report, the number of people developing diabetes around the globe is expected to continue to rise and increases are occurring in almost every country around the world. The current diagnosed figure is expected to climb from 370 million people currently living with diabetes to a number expected to exceed 550 million by 2030.  Approximately 80% of the current cases of diabetes are in low or middle income countries.

"Because diabetes unfortunately is one of the leading causes of ESRD, developing nations are expected to have a significant demand for dialysis therapy over the next 20 years," Carlson said.  "Our report goes into country-level analysis of those markets."

World Market for Dialysis Equipment and Services (United States, Japan, UK, Germany, France, Italy, India, China, Australia, Canada, Brazil, Mexico, South Africa, Russia and Other Nations) contains detailed reporting on markets related to dialysis, equipment and the provision of services in dialysis care centers and hospitals.  Market size and growth projections are provided for 22 countries.  Worldwide market share is computed and major companies in the market are reviewed.  The report can be obtained at http://www.marketresearch.com/redirect.asp?progid=87330&url=http%3A%2F%2Fwww%2Ekaloramainformation%2Ecom%2FDialysis%2DEquipment%2DServices%2D8827596%2F.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.  

Contact:
Bruce Carlson
(212) 807-2622
bcarlson@kaloramainformation.com

Logo - http://photos.prnewswire.com/prnh/20140801/132634

 

 


'/>"/>
SOURCE Kalorama Information
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Global Printed and Flexible Sensors 2013 Report: Forecasts, Players, Opportunities
2. Life Science Software - 2013 Market Report: Markets and Opportunities
3. The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics
4. D-Amino Acids - Global Strategic Business Report: Growing Interest in Peptide Research Drives D-Amino Acids Market
5. Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc.
6. Report: Radical New IVD Test Approaches Key To Growth
7. Report: Siemens Healthcare a Refocused IVD Competitor in 2015
8. Report: Tissue and Cell Diagnostics Market Nears 8 Billion
9. Genetic Technologies Analyst Report: No news drives GENE up 30% Issued by BrokerBank, Securities, Inc.
10. Report: Abbott Grows by Holding On to Core
11. Report: Sequencing-Based Test Market Already Highly Competitive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
(Date:6/28/2020)... JOSE, Calif. (PRWEB) , ... June 25, 2020 ... ... globe, researchers are racing to develop a vaccine or drug treatment. In an ... Recursion has publicly released the world’s largest imaging dataset portraying therapeutic ...
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today that ... during the American Association for Cancer Research Virtual meeting. One poster describes the ... single agent activity in KEAP1 mutant tumor models of NSCLC. , ...
Breaking Biology Technology:
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the ... PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall vision. ...
Breaking Biology News(10 mins):